Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Price:
3.08
USD
-6.38%
Market Closed
Market Cap:
$787.6m
Relative Value
The Relative Value of one
MRVI
stock under the Base Case scenario is
2.47
USD.
Compared to the current market price of 3.08 USD,
Maravai LifeSciences Holdings Inc
is
Overvalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MRVI
Relative Value
Base Case
2.47
USD
Overvaluation 20%
Multiples Across Competitors
MRVI Competitors Multiples
Maravai LifeSciences Holdings Inc Competitors
Maravai LifeSciences Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
|
788.5m USD | 4.4 | -6.2 | -11.8 | -7.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
949.8B USD | 332.5 | 3 937.7 | 1 128.4 | 2 172.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
174.7B USD | 3.9 | 26.1 | 18.4 | 24.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.4B USD | 5.4 | 36.6 | 18.7 | 27.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33B CHF | 5.1 | 34.9 | 26 | 26 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
259.4B CNY | 5.8 | 17.3 | 17.3 | 17.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.5B USD | 4.5 | 24.5 | 19.2 | 23 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.9B USD | 1.7 | 20.6 | 11.6 | 17.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.1B USD | 8.9 | 43.7 | 28.2 | 35.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
23.9B USD | 5.9 | 27.5 | 20.5 | 22.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
